ID
45672
Descrição
Principal Investigator: Pamela Madden, PhD, Washington University, St. Louis, MS, USA MeSH: Behavior, Addictive,Substance-Related Disorders https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001299 Ascertainment: Families were ascertained through panels of adult Australian twins, and a sample of spouses of Australian twins. Families with at least one offspring who was identified as a current or former smoker in an earlier survey. Screening telephone interviews were conducted with index cases to provide confirmation of a history of heavy cigarette smoking, to obtain confirmation of a history of heavy cigarette smoking, and to obtain additional information on the history of cigarette use and the survival status of other family members, and their full siblings and parents. Index cases were the affected spouse of a twin, or the affected twin from pairs discordant for a history of heavy smoking, or a randomly chosen twin from pairs where both have a history of regular smoking (i.e., has smoked at least 100 cigarettes lifetime), and at least one live biological parent to identify sibships with at least one affected sib pair (ASP) concordant for heavy smoking, and at least one living parent. If permission was granted by the index case, eligible family members were contacted and invited to provide a blood sample and to complete a telephone diagnostic interview. In families with just one available biological parent, and additional unaffected sibling who had never smoked on a regular basis (i.e., has smoked fewer than 100 cigarette lifetime, but has experimented with cigarettes once or twice) was included (when available) to help compensate for the loss of information due to missing parental phenotypes. (Target N=400 Australian families with approximately 600 ASPs; and 600 TDT trios comprised of a nicotine dependent index case and both biological parents). *Diagnostic Assessment*: The telephone diagnostic interview assessed DSM-IV and modified DSM-IIIR diagnoses (i.e., without time clustering) for nicotine dependence, alcohol and other drug dependence and abuse, major depression, and childhood conduct disorder. Most diagnostic assessments were based on the SSAGA/SSAGA-II, developed for the multi-site gene-mapping alcoholism study (the Collaborative Study on the Genetics of Alcohol. An exception was the tobacco section, which was developed directly from the CIDI and DIS (as the original SSAGA did not include a diagnostic section on nicotine dependence). In version 2 of this study, a text file containing 7704 SNPs with large allele frequency discrepancy as compared to 1000 Genomes is included. Users have the option to exlude these 7704 SNPs.
Link
Palavras-chave
Versões (1)
- 04/04/2023 04/04/2023 - Chiara Middel
Titular dos direitos
Pamela Madden, PhD, Washington University, St. Louis, MS, USA
Transferido a
4 de abril de 2023
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
dbGaP phs001299 Nicotine Addiction Genetics and Correlates
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- This subject consent data table informs of subject ID, subject consent group, source repository in which subject originated, ID assigned to the subject by the source repository, and subject's case - control status for nicotine dependence.
- This pedigree data table provides subject's family information including the mother and father of the subject. This pedigree table also informs of subject's sex.
- This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. This table also informs of the source repository in which the sample was obtained and the ID assigned to the sample by the source repository.
- This subject phenotypes data table provides information about the abuse and dependency status of the subject for: opioids, cocaine, alcohol, nicotine, cannabis, stimulants, sedatives, and 'other' drugs. It also informs of subject's age, sex, race, twin status, twin ID, live/death status, and the diagnostic system used on the subject.
- This sample attributes data table informs of body site where sample was collected and sample analyte type.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- This subject consent data table informs of subject ID, subject consent group, source repository in which subject originated, ID assigned to the subject by the source repository, and subject's case - control status for nicotine dependence.
- This pedigree data table provides subject's family information including the mother and father of the subject. This pedigree table also informs of subject's sex.
- This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. This table also informs of the source repository in which the sample was obtained and the ID assigned to the sample by the source repository.
- This subject phenotypes data table provides information about the abuse and dependency status of the subject for: opioids, cocaine, alcohol, nicotine, cannabis, stimulants, sedatives, and 'other' drugs. It also informs of subject's age, sex, race, twin status, twin ID, live/death status, and the diagnostic system used on the subject.
- This sample attributes data table informs of body site where sample was collected and sample analyte type.
C0680251 (UMLS CUI [1,2])
C0037047 (UMLS CUI [1,2])
C1709450 (UMLS CUI [1,3])
C1707689 (UMLS CUI [1,4])
C1512693 (UMLS CUI [2,1])
C1524062 (UMLS CUI [2,2])
C0522476 (UMLS CUI [2,3])
C0037047 (UMLS CUI [2,4])
C1512693 (UMLS CUI [3,1])
C1706086 (UMLS CUI [3,2])
C0337465 (UMLS CUI [3,3])
C1512693 (UMLS CUI [4,1])
C1524062 (UMLS CUI [4,2])
C0037047 (UMLS CUI [4,3])
C0522477 (UMLS CUI [4,4])
C0332157 (UMLS CUI [4,5])
C0543414 (UMLS CUI [4,6])
C1298908 (UMLS CUI [4,7])
C0205272 (UMLS CUI [4,8])
C0543414 (UMLS CUI [4,9])
C0205432 (UMLS CUI [4,10])
C4524803 (UMLS CUI [4,11])
C1707689 (UMLS CUI [5,1])
C0522476 (UMLS CUI [5,2])
C0037047 (UMLS CUI [5,3])
C1709450 (UMLS CUI [5,4])
C0936012 (UMLS CUI [5,5])
C0041427 (UMLS CUI [1,2])
C3846158 (UMLS CUI [1,3])
C0033522 (UMLS CUI [1,4])
C1516698 (UMLS CUI [1,5])
C1519386 (UMLS CUI [1,6])
C1511726 (UMLS CUI [1,7])
C0337669 (UMLS CUI [2,1])
C0600091 (UMLS CUI [2,2])
C3846158 (UMLS CUI [2,3])
C0041427 (UMLS CUI [3,1])
C4553529 (UMLS CUI [3,2])
C0337669 (UMLS CUI [3,3])
C0558295 (UMLS CUI [4,1])
C0041427 (UMLS CUI [4,2])
C1550543 (UMLS CUI [4,3])
C0243161 (UMLS CUI [4,4])
C0028043 (UMLS CUI [4,5])
C0242802 (UMLS CUI [4,6])
C2597943 (UMLS CUI [4,7])
C0205394 (UMLS CUI [5,1])
C0041427 (UMLS CUI [5,2])
C4699982 (UMLS CUI [5,3])